CME INDIA
  • Home
  • CME INDIA Repository
  • CME INDIA Case Study
  • History Today in Medicine
  • Future CMEs
  • About CME INDIA
Select Page
What Physicians Must Know about Approach to Recurrent Renal Calculi

What Physicians Must Know about Approach to Recurrent Renal Calculi

by Admin | Jan 17, 2025 | CME INDIA Repository

CME INDIA Presentation by Dr. Saptarshi Bhattacharya, MD, DM, Senior Consultant, Indraprastha Apollo Hospitals, New Delhi. (Based on a presentation at Hormone India Conference,11th-12th January, 2025, Bhopal. This presentation is inspired by Dr. Banshi Saboo,...
Diabetic Kidney Disease (DKD) – What Physicians Must Know?

Diabetic Kidney Disease (DKD) – What Physicians Must Know?

by Admin | Sep 30, 2023 | CME INDIA Repository

CME INDIA Presentation by Dr. Dinesh Agarwal, MD (Med), Diabetologist, Course Director – Advance Certificate Course in Diabetology, Dean – Academics and Research at Marwari Hospital, Guwahati, Assam, India. Based on a presentation at ICDM-2023 at Vadodara....
Sodium Bicarbonate Tablet & Acetyl Cysteine + Pyridoxamine Combination in CKD – What Physicians Must Know?

Sodium Bicarbonate Tablet & Acetyl Cysteine + Pyridoxamine Combination in CKD – What Physicians Must Know?

by Admin | Jun 30, 2023 | CME INDIA Repository

CME INDIA Presentation by Admin. Chronic metabolic acidosis refers to a condition in which there is a prolonged imbalance in the acid-base balance of the body, leading to excess acid accumulation. This condition is commonly observed in patients with chronic kidney...
Reduce Kidney Disease Progression or CV Death in People with CKD

Reduce Kidney Disease Progression or CV Death in People with CKD

by Admin | Nov 8, 2022 | CME INDIA Repository

CME INDIA Presentation by Dr. N. K. Singh, MD, FICP, FACP, F-RSSDI, Director – Diabetes and Heart Research Centre, Dhanbad, Jharkhand, India. Editor, www.cmeindia.in. Changing the way CKD interconnected conditions are being managed Empagliflozin was originally...
Is SGLT2-Inhibitors a New Nectar in Renal Protection in Diabetes?

Is SGLT2-Inhibitors a New Nectar in Renal Protection in Diabetes?

by Admin | Jun 9, 2022 | CME INDIA Repository

CME INDIA Presentation by Dr. N. K. Singh, MD, FICP, Director, Diabetes and Heart Research Centre, Dhanbad, Jharkhand, India. Editor, www.cmeindia.in. Based on the presentation at Diabetes India Conference 2022. Amazing changes in heart of SGLT2-Inhibitor treated...
« Older Entries

Latest Comments

  • Dr N K Singh on Semaglutide: Practical Prescribing Note for Physicians
  • Virat K on Semaglutide: Practical Prescribing Note for Physicians
  • Dr. T.S.Bheemaraju on History Today in Medicine – Prof. Dr. C. Palanivelu
  • Raghuveer Battula on History Today in Medicine – Prof. Dr. Tinsley R. Harrison
  • Swamikannu Murugan on History Today in Medicine – Prof. Dr. Tinsley R. Harrison

Latest Posts

  • History Today in Medicine – Prof. Sir Michael Woodruff
  • History Today in Medicine – Dr. James Douglas
  • History Today in Medicine – Prof. Dr. Shyamal Kumar Sen
  • History Today in Medicine – Dr. Acacio Gabriel Viegas
  • History Today in Medicine – Dr. T. S. Kanaka

Explore CME INDIA

  • About CME INDIA
  • CME INDIA Case Study
  • CME INDIA Downloads
  • CME INDIA Home
  • CME INDIA Repository
  • Future CMEs
  • History Today in Medicine
  • What is CME?
© CME INDIA™ 2026. All content on this site is for academic discussion only. Propelled by Dynamic Cognition.